L-thyroxine treatment and neurotransmitter levels in the cerebrospinal fluid of hypothyroid patients: a pilot study.
Monoamine precursors, neurotransmitters and their metabolites were studied in cerebrospinal fluid (CSF) obtained from nine newly diagnosed hypothyroid patients. Before treatment, the serum TSH correlated positively with the CSF concentrations of tyrosine and phenylalanine. During treatment, the levels of the precursors tryptophan, phenylalanine and tyrosine decreased significantly, as was also the case with dopamine and the noradrenaline metabolite 4-hydroxy-3-methoxyphenylglycol (HMPG), but not with serotonin, noradrenaline and the serotonin metabolite 5-hydroxyindoleacetic acid, nor the dopamine metabolites homovanilic acid and dihydroxyphenylacetic acid. The study provided some indication that the CSF levels of phenylalanine and tyrosine are related to thyroid function. Furthermore, we have found an indication that L-thyroxine treatment affects the CSF levels of the precursors as well as dopamine and HMPG. Our results support the notion that there is an interaction between thyroid function and CSF disposition of monoamine compounds.
Sjöberg
S
S
Department of Endocrinology and Metabolism, Karolinska Institute, Huddinge University Hospital, Sweden.
Eriksson
M
M
Nordin
C
C
D000328:Adult; D005260:Female; D006801:Humans; D007037:Hypothyroidism / Q000134:cerebrospinal fluid* / Q000188:drug therapy*; D008297:Male; D018377:Neurotransmitter Agents / Q000134:cerebrospinal fluid*; D010865:Pilot Projects; D013972:Thyrotropin / Q000097:blood; D013974:Thyroxine / Q000097:blood / Q000627:therapeutic use*; D014284:Triiodothyronine / Q000097:blood
D018377:Neurotransmitter Agents; D014284:Triiodothyronine; D013972:Thyrotropin; D013974:Thyroxine